Filter by: patients
Home > Community Treatment Reports and Side Effects > Methylprednisolone Treatment Report
What is Methylprednisolone?

Methylprednisolone is a synthetic corticosteroid drug used primarily as an anti-inflammatory or immunosuppressant agent for diseases of hematologic, allergic, inflammatory, neoplastic, and autoimmune origin; also for graft-versus-host disease.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
MS (Multiple Sclerosis) 480 165 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Other 196 42 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Relapse MS (exacerbation) 135 65 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Stiffness/Spasticity 68 20 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Pain 61 16 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_cant_tell
Prevent organ rejection 58 7 Efficacy_major Efficacy_slight Efficacy_cant_tell

See all 503 patients currently taking Methylprednisolone

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 85
Moderate
 133
Mild
 140
None
 96

Commonly reported side effects, conditions, and hospitalizations associated with Methylprednisolone

Insomnia 60
Metallic taste in mouth 58
Weight gain 47
Taste changed 45
Sleeplessness 43
Increased appetite 32
See all 232 reported side effects ▼ See top 6 reported side effects ▲

Reported Dosages

Frequently reported dosages based on patients currently taking Methylprednisolone. See all 155 dosages ►

  1g as needed 1,000mg as needed daily 1 g monthly 1 g daily 2 mg daily 4 mg daily 5 mg daily 8 mg daily 1,000 mg daily
  27 Number of Patients: 27 13 Number of Patients: 13 15 Number of Patients: 15 33 Number of Patients: 33 50 Number of Patients: 50 13 Number of Patients: 13 41 Number of Patients: 41 17 Number of Patients: 17 15 Number of Patients: 15 28 Number of Patients: 28  

Reported Stop Reasons

Why Patients Stopped Taking Methylprednisolone (multiple reasons could be selected)
Reason # Patients Percentage of patients
Course of treatment ended 788   Course of treatment ended: 80%
Doctor's advice 116   Doctor's advice: 12%
Did not seem to work 68   Did not seem to work: 7%
Side effects too severe 56   Side effects too severe: 6%
Other 49   Other: 5%
Not indicated 45   Not indicated: 5%
Personal research 7   Personal research: 1%
Change in health plan coverage 5   Change in health plan coverage: 1%
Expense 4   Expense: 0%

See all 965 patients who’ve stopped taking Methylprednisolone

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Methylprednisolone

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Stopped Taking Methylprednisolone

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Methylprednisolone

Always
 400 88%
Usually
 22 5%
Sometimes
 17 4%
Never
 15 3%

Burden

Difficulty being on treatment

Burden of Methylprednisolone

Very
 31 7%
Somewhat
 112 25%
A little
 120 26%
Not at all
 191 42%

Cost

Paid out of pocket

Cost of Methylprednisolone

$200+
 27 11%
$100-199
 17 7%
$50-99
 17 7%
$25-49
 13 5%
< $25
 169 68%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 28, 2012.